Development of novel score based on Angiogenic panel for accurate diagnosis of hepatocellular carcinoma among hepatitis C virus high-risk patients.
CONCLUSION: HCC-AngioScore could replace AFP during screening of HCV patients and early detection of HCC.
PMID: 32987190 [PubMed - as supplied by publisher]
Source: Infection, Genetics and Evolution - Category: Genetics & Stem Cells Authors: Abdelgawad ME, Darwish H, Nabawy MM, El-Mezayen H Tags: Infect Genet Evol Source Type: research
More News: Cancer & Oncology | Carcinoma | Cirrhosis | Copper | Genetics | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Laboratory Medicine | Liver | Liver Cancer | Urology & Nephrology